JONATHAN HODGIN: Open Payments
NPI 1841811437 · GREER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,870 in 77 payments from 19 companies in 2025. Trend: 2023 $1,872 · 2024 $2,063 · 2025 $1,870
Food & beverage: $1,580Education: $289
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $249 |
| Regeneron Healthcare Solutions, Inc. | 5 | $246 |
| Incyte Corporation | 9 | $199 |
| GENZYME CORPORATION | 10 | $188 |
| ABBVIE INC. | 7 | $168 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $157 |
| E.R. Squibb & Sons, L.L.C. | 10 | $139 |
| PFIZER INC. | 2 | $122 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| UCB, Inc. | 2 | $69 |
Products named: DUPIXENT, TREMFYA, OPZELURA, SKYRIZI, Sotyktu, LITFULO, ILUMYA, Bimzelx.
Industry payments across SC — which companies pay providers there.
